X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.fiercebiotech.com/biotech/nearly-week-after-pulling-relyvrio-amylyx-engage-regulators-about-path-another-rare-disease
https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-formal-intention-to-remove-relyvrior/albriozatm-from-the-market-provides-updates-on-access-to-therapy-pipeline-corporate-restructuring-and-strategy
https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-topline-results-from-global-phase-3-phoenix-trial-of-amx0035-in-als
https://www.fiercepharma.com/pharma/amylyxs-als-drug-relyvrio-rebuffed-eus-chmp-again
https://endpts.com/european-regulatory-committee-recommends-rejecting-amylyx-als-drug/
https://endpts.com/amylyx-says-relyvrio-earns-71m-in-revenue-plans-to-test-drug-in-rare-brain-disorder/
https://endpts.com/amylyx-welcomes-former-alnylam-exec-to-help-expand-relyvrio-amarin-plugs-in-an-interim-chief/
https://www.fiercepharma.com/special-reports/2022-drug-approvals-after-aduhelm-fiasco-fda-endorsements-were-harder-come
https://www.fiercepharma.com/pharma/amylyxs-als-drug-finally-scores-fda-approval-thats-just-tip-iceberg-als-research-amylyx-co
https://investors.amylyx.com/news-releases/news-release-details/amylyx-pharmaceuticals-announces-donated-centaur-clinical-trial
https://www.fiercebiotech.com/orion-take-repurposed-heart-failure-drug-into-phase-3-for-als
http://www.rcinet.ca/en/2015/09/14/prion-alzheimers-parkinsons-canadian-advance-in-solving-brain-disease/
Market Place
Share 
